Now Available: Adocia (ADOC) - Product Pipeline Analysis, 2013 Update
Adocia, formerly Proteins & Peptides Management S.A.S. is a biotechnology company. It specializes in insulin therapy and the treatment of the diabetic foot ulcer. The company controls the activity of therapeutic proteins through its BioChaperone state-of-the-art technological platform. Its pipeline products include BioChaperone PDGF for chronic wound healing, BioChaperone insulins for insulinotherapy and BioChaperone for monoclonal antibodies. The company has completed two phases I and II studies on the formulation of a fast-acting human insulin and has received adequate phase...
View full press release